JNJ Earnings & Financial Statements
Johnson & Johnson
$253.91
+$5.30(+2.13%)
56
Overall
70
Value
50
Tech
50
Quality
Market Cap
$599.12B
Volume
9.64M
52W Range
$184.66 - $281.07
Target Price
$282.76
JNJ earnings and financial statements: Johnson & Johnson's income statement, balance sheet and cash flow statement, annual and quarterly.
JNJ Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $94.19B | $88.82B | $85.16B | $79.99B | $93.78B |
| Cost of revenue | $30.26B | $27.47B | $26.55B | $24.60B | $23.40B |
| Operating income | $25.60B | $21.25B | $22.01B | $21.01B | $23.65B |
| EBITDA | $41.05B | $24.78B | $45.15B | $26.61B | $29.83B |
| Net income | $26.80B | $14.07B | $35.15B | $17.94B | $20.88B |
| EPS (diluted) | $11.03 | $5.79 | $13.72 | $6.73 | $7.81 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $199.21B | $180.10B | $167.56B | $187.38B | $182.02B |
| Total liabilities | $117.67B | $108.61B | $98.78B | $110.57B | $108.00B |
| Shareholders’ equity | $232.79B | $222.85B | $220.10B | $160.19B | $152.22B |
| Cash and equivalents | $19.71B | $24.11B | $21.86B | $12.89B | $14.49B |
| Long-term debt | $39.44B | $30.65B | $25.88B | $26.89B | $29.98B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $24.53B | $24.27B | $22.79B | $21.19B | $23.41B |
| Capital expenditure | -$4.11B | -$3.75B | -$5.01B | -$4.01B | -$3.65B |
| Free cash flow | $19.70B | $19.84B | $17.78B | $17.18B | $19.76B |
| Dividends paid | $12.38B | $11.82B | $11.77B | $11.68B | $11.03B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JNJ | $253.91 | +2.1% | 9.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |